Khalid S Mohammad

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Advanced Cancer

Bone Regeneration

Transforming Growth Factor

Top Venues

International journal of molecular sciences

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Basant Elaasser, Nour Arakil, Khalid S Mohammad
Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective. International journal of molecular sciences 25 (5) (2024)
Ahmad Dawalibi, Amal Ahmed Alosaimi, Khalid S Mohammad
Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments. International journal of molecular sciences 25 (15) (2024)
Nour Arakil, Shahid Akhtar Akhund, Basant Elaasser, Khalid S Mohammad
Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis. Biomedicines 12 (5) (2024)
Ahmad Dawalibi, Amal Ahmed Alosaimi, Khalid S Mohammad
Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments. International journal of molecular sciences 25 (15) (2024)
Basant Elaasser, Nour Arakil, Khalid S Mohammad
Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective. International journal of molecular sciences 25 (5) (2024)
Basant Elaasser, Nour Arakil, Khalid S Mohammad
Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective. International journal of molecular sciences 25 (5) (2024)
Nour Arakil, Shahid Akhtar Akhund, Basant Elaasser, Khalid S Mohammad
Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis. Biomedicines 12 (5) (2024)
Yang Liu, Steven Reiken, Haikel Dridi, Qi Yuan, Khalid S Mohammad, Trupti Trivedi, Marco C Miotto, Kaylee Wedderburn-Pugh, Leah Sittenfeld, Ynez Kerley, Jill A Meyer, Jonathan S Peters, Scott C Persohn, Amanda A Bedwell, Lucas L Figueiredo, Sukanya Suresh, Yun She, Rajesh Kumar Soni, Paul R Territo, Andrew R Marks, Theresa A Guise
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice. Science translational medicine 15 (715) (2023)